Brief: Mineralys Therapeutics Reports Q4 And Full Year 2022 Financial Results And Provides Corporate Update
15/03/2023 20:02
March 15 (Reuters) - Mineralys Therapeutics Inc
MLYS.O :
* MINERALYS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR 2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* MINERALYS THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.74
Source text for Eikon: ID:nGNX3pxnQh
Further company coverage: MLYS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway